BAPCOR News & Analysis

This moated ASX company's shares are in a prolonged slump. I quizzed our analyst Angus Hewitt on its management, the potential impact of EVs, and...

It hasn't been smooth sailing for these two companies recently. But our analysts disagree with how markets are assessing their future prospects.

Our analysts disagree with how the market is valuing these ASX companies. Next week’s earnings reports could offer some clues as to whether we are...

I put Bapcor through a quick but insightful test suggested in one of my favourite investing books.

We believe the bid is an attempt to capitalise on share price weakness. 

Most of Bapcor’s earnings aren’t exposed to slowing discretionary spending.

The discretionary slowdown weighs on retail, but maintenance remains resilient.

Fears of a discretionary spending pullback are hitting this auto parts supplier, but the resulting selloff may be overdone, according to...

The car parts supplier is expanding its footprint and the longer-term is positive despite the recent hit to vehicle sales.

American biotech company Intercept Pharmaceuticals and seed and crop chemicals producer Corteva have entered Morningstar’s Global Best Equity Ideas...